EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access · CC BY-NC-ND 4.0

Safety of a trial of labor after cesarean in kidney and liver transplant recipients: A multicenter cohort study

Anjali Walia iD, Ophelia Yin, Lisa A Coscia, Serban Constantinescu, Monika Sarkar, Michael J Moritz, Yalda Afshar, Roxanna A Irani iD

International Journal of Gynecology & Obstetrics · 2025

DOI: 10.1002/ijgo.70013 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift International Journal of Gynecology & Obstetrics, 2025. Verfasst von Anjali Walia und 7 weiteren Autor:innen. Beteiligte Einrichtung: University of California San Francisco School of Medicine, San Francisco, California, USA. Hauptthemen laut MEDLINE: Trial of Labor, Vaginal Birth after Cesarean, Liver Transplantation, Kidney Transplantation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NICHD NIH HHS, Veloxis Pharmaceuticals, Eunice Kennedy Shriver National Institute of Child Health and Human Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate the trends, safety, and feasibility of a trial of labor after cesarean (TOLAC) among kidney and liver transplant recipients.

Methods

This was a retrospective cohort study using the Transplant Pregnancy Registry International. It included recipients of a kidney or liver transplant with a live‐birth pregnancy ≥20 weeks following a prior cesarean, with births between 1967 and 2019 from 289 hospitals, primarily in North America. The primary outcomes of severe maternal morbidity (SMM) and neonatal composite morbidity were compared between those with repeat cesarean deliveries (RCDs), vaginal births after cesarean (VBACs), and failed TOLAC. Multivariable regression was conducted to calculate odds ratios and 95% confidence intervals.

Results

The 243 deliveries included in this study were composed of 80.7% RCDs, 10.3% VBACs, and 9.1% with failed TOLAC, with similar demographics between groups. There was no significant difference in incidence of SMM (RCD, 1.0%; VBAC, 4.0%; failed TOLAC, 0%; P = 0.48) or neonatal composite morbidity (RCD, 15.2%; VBAC, 11.5%; failed TOLAC, 4.5%; P = 0.45) between groups. No cases of uterine rupture or neonatal death occurred. Trends in TOLAC demonstrate that the TOLAC rate has declined from 35% in 1989–1994 to 13% in 2014–2019.

Conclusions

In this cohort of transplant recipients, TOLAC resulted in successful vaginal delivery over half the time, and did not increase the risk of maternal or neonatal morbidity compared with RCD. We encourage offering transplant recipients a trial of labor after appropriate counseling to decrease the overall rate of cesarean delivery and morbidity in this high‐risk population.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Trial of LaborVaginal Birth after CesareanLiver TransplantationKidney TransplantationHumansFemalePregnancyAdultRetrospective StudiesCesarean Section, RepeatInfant, NewbornPregnancy OutcomeTransplant RecipientsRegistries

Stichwörter der Autor:innen

maternal morbidityneonatal morbidityrepeat cesareantransplanttrial of labor after cesareanvaginal birth after cesarean

Autor:innen und Institutionen

  • University of California San Francisco School of Medicine, San Francisco, California, USA.
  • Division of Maternal Fetal Medicine and Reproductive Genetics, Department of Obstetrics, Gynecology, and Reproductive Sciences, University of California San Francisco, San Francisco, California, USA.
  • Transplant Pregnancy Registry International, Gift of Life Institute, Philadelphia, Pennsylvania, USA.
  • Section of Nephrology, Hypertension, and Kidney Transplantation, Department of Medicine, Lewis Katz School of Medicine, Temple University, Philadelphia, Pennsylvania, USA.
  • Division of Transplant Hepatology, Department of Medicine, University of California San Francisco, San Francisco, California, USA.
  • Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, California, USA.

ORCID-Profile: Anjali Walia, Roxanna A Irani

Förderung

  • NICHD NIH HHS
  • Veloxis Pharmaceuticals
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development

Zitieren

APA

Walia, A., Yin, O., Coscia, L. A., Constantinescu, S., Sarkar, M., Moritz, M. J., Afshar, Y., & Irani, R. A. (2025). Safety of a trial of labor after cesarean in kidney and liver transplant recipients: A multicenter cohort study. International Journal of Gynecology & Obstetrics. https://doi.org/10.1002/ijgo.70013

Vancouver

Walia A, Yin O, Coscia LA, Constantinescu S, Sarkar M, Moritz MJ, et al. Safety of a trial of labor after cesarean in kidney and liver transplant recipients: A multicenter cohort study. International Journal of Gynecology & Obstetrics. 2025. doi:10.1002/ijgo.70013

BibTeX
@article{Walia2025,
  author = {Walia, Anjali and Yin, Ophelia and Coscia, Lisa A and Constantinescu, Serban and Sarkar, Monika and Moritz, Michael J and Afshar, Yalda and Irani, Roxanna A},
  title = {Safety of a trial of labor after cesarean in kidney and liver transplant recipients: A multicenter cohort study},
  journal = {International Journal of Gynecology & Obstetrics},
  year = {2025},
  doi = {10.1002/ijgo.70013}
}
Kostenlos starten →